Metraipolis › archive › dc_14a8c6491c8d

UBE2M Identified by CRISPR Screening as a Key Regulator of Cisplatin-Induced Acute Kidney Injury via the p53 Pathway — Europe PMC PMID:41832622

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41832622
DOI
10.2174/0118715303410982251112055248
License (as archived)
solo-consultazione
Archived
2026-11-07T06:11:01.990Z
SHA-256 of the archived text
3505ec8f60cb44de088685ac75019afe2c022b52639b02558b9198bdfa4cb7ee
Stable URL of this page
https://metraipolis.com/documento/dc_14a8c6491c8d

How to cite

UBE2M Identified by CRISPR Screening as a Key Regulator of Cisplatin-Induced Acute Kidney Injury via the p53 Pathway — Europe PMC PMID:41832622 — Europe PMC (en), https://europepmc.org/article/MED/41832622 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_14a8c6491c8d (Metraipolis archive dc_14a8c6491c8d, sha256 3505ec8f60cb44de088685ac75019afe2c022b52639b02558b9198bdfa4cb7ee)
BibTeX
@misc{dc14a8c6491c8d,
  title = {UBE2M Identified by CRISPR Screening as a Key Regulator of Cisplatin-Induced Acute Kidney Injury via the p53 Pathway — Europe PMC PMID:41832622},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41832622},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_14a8c6491c8d; sha256 3505ec8f60cb44de088685ac75019afe2c022b52639b02558b9198bdfa4cb7ee},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41832622. Agents can read the archived copy with the MCP tool read_document.